What changed
Revenue grew 6.5% to $975.3m, reversing the prior-year decline of similar magnitude, with Retail & Water (approximately 79% of revenue) and Agency both contributing. Gross margin widened modestly by about 40 basis points to 26.1%, indicating that the revenue recovery carried slightly better quality than the prior cycle.
Operating EBITDA rose 27.1% to $56.1m — the leverage effect from largely fixed operating costs amplifying the revenue recovery. PBT more than doubled to $14.0m from $5.3m, the cleaner operating read given tax distortion. NPAT of $10.7m appears to grow 248% year on year, but the effective tax rate fell to approximately 23.8% from 42.5% in FY24; PBT growth of 162.6% is the more comparable measure.
The material deterioration is in cash. Operating cash flow collapsed to $12.4m from $57.7m, and after capex of $17.4m, pre-lease free cash flow was negative at approximately -$5.0m. Trade debtors increased $19.4m (17.7%) to $128.9m, lengthening receivable days from 44 to 48 days. Gross borrowings rose 40% to $88.2m, lifting net debt to approximately $85.6m from $59.2m and pushing net debt/EBITDA to roughly 1.5x.
A fully imputed final dividend of 4 cents per share was declared; combined with the interim of 2.5 cents, the full-year dividend totals 6.5 cents per share. No final dividend was paid in FY24.
What matters
Cash conversion deteriorated sharply and is the dominant concern. Operating cash flow of $12.4m against EBITDA of $56.1m implies a conversion ratio of approximately 22%, compared with 131% in FY24. The primary driver appears to be working capital absorption — trade debtors alone consumed approximately $19.4m — but payables are not separately disclosed, so the full working capital picture is incomplete. A business recovering volume after a downturn will naturally build receivables, but the scale of the swing warrants scrutiny of credit quality and collection terms.
Leverage has moved in the wrong direction despite the earnings recovery. Net debt increased approximately $26.4m to $85.6m while EBITDA rose $12.0m. The net debt/EBITDA ratio widened to roughly 1.5x. With free cash flow negative and a dividend now being paid out of borrowings in effect, the balance sheet trajectory is weakening even as the income statement improves.
The EBITDA outcome beat interim guidance materially. At the half year, management reaffirmed FY25 Operating EBITDA guidance of "around $51m"; the full-year result came in at $56.1m — approximately $5m above that level. The beat is creditable and suggests the second-half trading environment was better than the cautious guidance implied. However, this beat was concentrated in the first half: HY25 contributed 73.7% of full-year EBITDA, and the implied second-half NPAT was negative at approximately -$5.3m.
Expectations
No formal FY26 earnings targets are provided in the filing. The interim guidance of approximately $51m Operating EBITDA was the only stated forward benchmark, and FY25 outperformed it by approximately $5m. Seasonality is clearly first-half weighted at PGW — HY25 represented 58.5% of full-year revenue and 73.7% of EBITDA — consistent with the autumn input and livestock trading cycle in the New Zealand agri-sector.
The FY24 comparative was itself a weak year (EBITDA had fallen $17m versus FY23), so the FY25 recovery is partly a mean reversion. FY23 EBITDA was approximately $61.2m per the prior-period disclosure; FY25 at $56.1m is still below that level. The release characterises the agri-sector as "continued to recover," suggesting management does not consider the cycle complete. No forward-work pipeline or order-book data is disclosed to independently verify that view.
The dividend reinstatement at 6.5 cents for the full year signals management confidence, but given negative free cash flow, the dividend is currently being funded by increased borrowings rather than operations.
Quality of result
The EBITDA recovery has genuine operating substance — revenue grew, gross margin held, and the business did not rely on disclosed one-off gains. No non-recurring items were identified in the supplied excerpts. On that basis the earnings recovery is directionally real.
However, several features reduce confidence that the FY25 result is fully repeatable at current quality:
- The receivables build of $19.4m is the primary drag on cash quality. Whether this reflects extended credit terms offered to customers in a recovering but still-stressed farm sector, or simply volume timing, is not resolved by the filing.
- The second half was loss-making at the NPAT level (approximately -$5.3m implied), meaning the strong headline was almost entirely a first-half story. This introduces sequencing risk for FY26.
- The effective tax rate normalised in FY25; the FY24 rate of 42.5% was abnormally high, so the NPAT growth rate flatters the year-on-year narrative. PBT at $14.0m — a thin margin on $975m of revenue — remains the more honest earnings indicator.
- The dividend is not covered by free cash flow, which is a capital discipline question rather than an earnings quality question per se, but it does add to balance sheet pressure.
Unresolved
- What is the credit quality of the enlarged receivables book? Receivable days of 48 on a $975m revenue base implies approximately $129m outstanding; any deterioration in farm-sector credit would flow directly to provisions and cash.
- What drove the effective tax rate halving from 42.5% to 23.8%? Without a tax note breakdown, it is unclear whether this is structural (deferred tax asset recognition, rate changes) or timing-driven.
- Is the second-half NPAT loss (-$5.3m implied) driven by seasonal cost phasing, specific trading weakness, or below-the-line items not visible in summary disclosures?
- Gross borrowings rose $25.2m to $88.2m; the purpose and refinancing terms of this facility expansion are not disclosed, introducing refinancing-risk uncertainty.
- Management describes the agri-sector as still recovering; no quantification is provided of what normalised earnings look like or when recovery is expected to be complete.
This briefing cannot assess counterparty credit risk within the receivables book or whether the working capital build is temporary volume-timing or structural credit deterioration.
Key metrics
| Metric | FY25 | FY24 | Change |
|---|---|---|---|
| Revenue | $975.3m | $915.9m | +6.5% ↑ |
| EBITDA | $56.1m | $44.2m | +27.1% ↑ |
| Net profit after tax | $10.7m | $3.1m | +248.0% ↑ |
| Net cash inflow from operating activities | $12.4m | $57.7m | -78.5% ↓ |
| Final dividend per share | 4.0c | 0.0c | ↑ |
| Operating profit | $26.2m | $15.4m | +70.5% ↑ |
| Profit before tax | $14.0m | $5.3m | +162.6% ↑ |
| Cash and cash equivalents | $2.6m | $3.8m | -31.0% ↓ |
| Total assets | $529.7m | $477.6m | +10.9% ↑ |
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Agency | $201.0m | $180.7m | $7.1m | +0.9pp |
| Retail & Water | $773.0m | $733.6m | $15.9m | -0.9pp |
Analytical metrics
| Metric | FY25 | FY24 | Context |
|---|---|---|---|
| PBT growth | +162.6% | — | cleaner earnings measure |
| Effective tax rate | 23.8% | 42.5% | — |
| OCF / EBITDA (cash conversion) | 22.1% | 130.7% | deteriorated |
| FCF pre-lease | −$5.0m | $34.9m | −$39.9m |
| FCF / NPAT | -47.2% | n/m | complementary conversion metric |
| Capex % revenue | 1.8% | 2.5% | — |
| Capex | $17.4m | $22.8m | −$5.4m |
| Debtor days | 48.3 | 43.7 | +4.6 days |
| Inventory days | 50.7 | 51.1 | -0.4 days |
| Operating working capital | $229.0m | $204.7m | +$24.3m absorbed |
| Trade debtors | $129.0m | $109.5m | +$19.4m |
| Net debt | $85.6m | $59.2m | +$26.4m |
| Net debt / EBITDA | 1.52x | 1.34x | Weakening |
| Gross borrowings | $88.2m | $63.0m | +$25.2m |
| Payout ratio vs NPAT | 28.4% | — | — |
| Payout ratio vs FCF pre-lease | -60.2% | — | not covered |
| ROE (annualised) | 6.1% | 1.9% | Strengthening |
| HY25 share of FY25 revenue | 58.5% | — | Other half was 41.5% |
| HY25 share of FY25 EBITDA | 73.7% | — | Other half was 26.3% |
| HY25 share of FY25 NPAT | 149.8% | — | Other half was -49.8% |
| Profit from continuing operations | $10.7m | — | — |
This analysis was generated using Annolyse, an AI-powered tool that extracts and analyses NZX/ASX company announcements. The underlying data is extracted from official company filings and verified against source documents. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.